Q-Line Biotech (NSE:QLINE) Inventories, Finished Goods: ₹366 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
14 GF Score
Price ₹531.80
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Inventories, Finished Goods?

Q-Line Biotech NSE:QLINE -1.12% 14 Inventories, Finished Goods is ₹366 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's quarterly finished goods increased from Mar. 2023 (₹353 Mil) to Mar. 2024 (₹598 Mil) but then declined from Mar. 2024 (₹598 Mil) to Mar. 2025 (₹366 Mil).

Q-Line Biotech's annual finished goods increased from Mar. 2023 (₹353 Mil) to Mar. 2024 (₹598 Mil) but then declined from Mar. 2024 (₹598 Mil) to Mar. 2025 (₹366 Mil).

Q-Line Biotech Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Inventories, Finished Goods Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Inventories, Finished Goods
352.69 598.12 366.38

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Inventories, Finished Goods 352.69 598.12 366.38
NSE:QLINE
14GF Score
Q-Line Biotech Ltd NSE:QLINE
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹366 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Inventories, Finished Goods of ₹366 Mil as of Mar. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Inventories, Finished Goods too high?
Q-Line Biotech's current Inventories, Finished Goods is ₹366 Mil. Overall, Q-Line Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Inventories, Finished Goods compare to ABT and SYK?
Q-Line Biotech's Inventories, Finished Goods of ₹366 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Inventories, Finished Goods is ₹366 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Inventories, Finished Goods of ₹366 Mil. The current Inventories, Finished Goods is ₹366 Mil. Q-Line Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Inventories, Finished Goods is ₹366 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
14GF Score

Get the complete analysis for NSE:QLINE

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹531.80
Price